Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Magali Lacroix Triki
Based on 38 articles published since 2009
(Why 38 articles?)
||||
Expertise Level
The expertise of Magali Lacroix Triki ranks in the
  • Top 0.6%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 38 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Lacroix-Triki, Magali   ·   Lacroix Triki, Magali   ·   Lacroix-Triki, M
Work Locations
Details
Most likely:    Institut Gustave Roussy      
2019
  • Institut de Génétique Humaine, CNRS, Université de Montpellier, Equipe Labellisée Ligue Contre le Cancer, 34396, Montpellier, France. · Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany. · Cancer Research Center of Toulouse, INSERM U1037, CNRS ERL5294, University of Toulouse 3, 31037, Toulouse, France. · Clinical trials Office - Biostatistics Unit, Institute Claudius Regaud, Institute Universitaire du Cancer Toulouse-Oncopole (IUCT-O), 31100, Toulouse, France. · Thoracic Oncology Department, Toulouse University Hospital, University Paul Sabatier, 31062, Toulouse, France. · Gustave Roussy Cancer Campus, 94805, Villejuif, France. · The Institute of Cancer Research, London, SW3 6JB, UK. · Institut de Génétique Humaine, CNRS, Université de Montpellier, Equipe Labellisée Ligue Contre le Cancer, 34396, Montpellier, France. · Institut de Génétique Humaine, CNRS, Université de Montpellier, Equipe Labellisée Ligue Contre le Cancer, 34396, Montpellier, France. · Pubmed 30796221
  • Department of Molecular Medicine, INSERM U981, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94800, Villejuif, France. · LabEx LERMIT, University Paris Saclay, 5 Rue J-B Clément, 92296, Châtenay-Malabry, France. · University Paris Sud, 63 rue Gabriel Peri, 94270, Le Kremlin-Bicetre, France. · Inovarion, 75013, Paris, France. · Department of Medical Oncology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94800, Villejuif, France. · Pathology Department, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France. · Department of Medical Biology and Pathology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Translational Research Department, Breast Cancer Biology Group, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005 Paris, France. · Department of Molecular Medicine, INSERM U981, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94800, Villejuif, France. · LabEx LERMIT, University Paris Saclay, 5 Rue J-B Clément, 92296, Châtenay-Malabry, France. · University Paris Sud, 63 rue Gabriel Peri, 94270, Le Kremlin-Bicetre, France. · Pubmed 30368744
2018
  • ICO René Gauducheau, Saint-Herblain, France. Electronic address: · Gustave Roussy, Villejuif, France. · Centre Val D'Aurelle, Montpellier, France. · University Hospitals Leuven and KULeuven, Leuven, Belgium. · Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Centre François Baclesse, Caen, France. · Centre Georges-François Leclerc, Dijon, France. · Centre Léon Bérard, Lyon, France. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jean Godinot, Reims, France. · Centre Alexis Vautrin, Nancy, France. · Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · University of AntwerpAZ, Belgium. · Clinique Tivoli, Bordeaux, France. · Polyclinique de Courlancy, Reims, France. · CH de Fleyriat, Bourg en Bresse, France. · Grand Hopital de Charleroi, Charleroi, Belgium. · R&D UNICANCER, UCBG, Paris, France. · Institut Claudius Regaud, IUCT Oncopole, Toulouse, France. · Pubmed 30267987
  • Département de Biologie et Pathologie des Tumeurs, Centre Georges-François Leclerc - Unicancer, 1 rue Professeur Marion, 21000, Dijon, France. · Département de Biopathologie, Institut Bergonié, 229 cours de l'Argonne, 33076, Bordeaux, France. · Département de Biologie et Pathologie des Tumeurs, Centre Georges-François Leclerc - Unicancer, 1 rue Professeur Marion, 21000, Dijon, France. · Département de Pathologie, Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Service d'Anatomie et Cytologie Pathologiques, Centre Hospitalier Universitaire de Besançon, 25030, Besançon Cedex, France. · Cypath Lyon, 201 route de Genas, 69100, Villeurbanne, France. · Département de Pathologie, Institut Curie, Saint Cloud, 35 rue Dailly, 92210, Saint Cloud, France. · Medipath Cannes-Antibes-Grasse, 80 allée des ormes, 06250, Mougins, France. · Pathologie Nord Unilabs, 60 boulevard Jean Baptiste Lebas, 59000, Lille, France. · Centre de Pathologie, 13 rue Carnot, 65000, Tarbes, France. · Atalante Pathologie, 10 rue J-Louis Bertrand -BP11633, 35016, Rennes cedex, France. · Pubmed 29785016
  • Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Biostatistics, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005 Paris & Saint-Cloud, France. · Department of Medical Oncology, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Bergonié, 229 Cours de L'Argonne, 33000 Bordeaux, France. · Department of Medical Oncology, Institut Du Cancer de Montpellier, 208 Rue des Apothicaires, 34298 Montpellier, France. · Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011 Clermont Ferrand, France. · Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059 Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes & Angers, 15 rue André Boquel, 49055 Angers, France. · Department of Medical Oncology, Centre Antoine Lacassagne, 33 Avenue de Valambrose, 06189 Nice, France. · Department of Medical Oncology, Centre François Baclesse, 3 Avenue du Général Harris, 14000 Caen, France. · Department of Medical Oncology, Centre Georges François Leclerc, 1 rue Professeur Marion, 21079 Dijon, France. · Medical Oncology Department, Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000 Lille, France. · Medical Oncology Department, Centre Eugéne Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000 Rennes, France. · INSERM CIC1401, Institut Bergonie, Comprehensive Cancer Center, F-33000 Bordeaux, France. · Department of Medical Oncology, Centre Paul Strauss, 3 Rue de la Porte de l'Hôpital, 67000 Strasbourg, France. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, 1 Rue du Général Koenig, 51100 Reims, France. · Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, 6 Avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France. · Department of Medical Oncology, Centre Henri Becquerel, Rue d'Amiens, 76000 Rouen, France. · Department of BioPathology, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654 Paris, France. · Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Pubmed 29660596
2017
  • Département de biologie et pathologie médicales, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Service de pathologie, centre François-Baclesse, avenue du Général-Harris, 14076 Caen cedex 5, France. · Département de biologie et pathologie médicales, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Pubmed 28159402
2016
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Probable:    Miscellaneous institutions in Toulouse      
2018
  • Department of Biopathology, Centre Jean Perrin and EA 4677 ERTICa, Université d'Auvergne, 58 rue Montalembert, 63000, Clermont-Ferrand, France. · Department of Biostatistics, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Institut Curie, Paris, France. · Genomic Health Inc, Redwood City, CA, USA. · University of California, San Francisco, CA, USA. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France. · Department of Pathology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Centre Val d'Aurelle, Montpellier, France. · Department of Pathology, Institut de Cancérologie de l'Ouest (site René Gauducheau), Nantes, Saint-Herblain, France. · Unicancer, Paris, France. · Department of Medical Oncology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Pubmed 29728098
2017
  • Team "Cholesterol Metabolism and Therapeutic Innovations," Cancer Research Center of Toulouse (CRCT), UMR 1037, Université de Toulouse, CNRS, Inserm, UPS, 31037 Toulouse, France. · Université Paul Sabatier, 31062 Toulouse, France. · Affichem, 31400 Toulouse, France. · Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, 31059 Toulouse, France. · Vascular Biology, Atherothrombosis & Mass Spectrometry Laboratory, Sapienza University of Rome, 04100 Latina, Italy. · l'Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, University of Montpellier, F-34298 Montpellier, France. · INSERM/UPS-US006/Centre Régional d'Exploration Fonctionnelle et Ressources Expérimentales, Service d'Histopathologie, Centre Hospitalier Universitaire Purpan, 31024 Toulouse, France. · Pôle Technologique, Cancer Research Center of Toulouse (CRCT), Plateau Interactions Moléculaires, INSERM-UMR1037, 31037 Toulouse, France. · Team "Cholesterol Metabolism and Therapeutic Innovations," Cancer Research Center of Toulouse (CRCT), UMR 1037, Université de Toulouse, CNRS, Inserm, UPS, 31037 Toulouse, France; · Pubmed 29078321
2016
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
2015
  • Département de pathologie, IUCT-Oncopole 1, avenue Irène Joliot-Curie, 31059 Toulouse cedex 9, France. · Département de pathologie, IUCT-Oncopole 1, avenue Irène Joliot-Curie, 31059 Toulouse cedex 9, France. Electronic address: · Pubmed 26118875
  • Department of Medical Oncology, Institut du Cancer de Montpellier, 208 avenue des Apothicaires, 34298 Montpellier Cedex 5, France. · Department of Pathology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Methodological and Quality of Life in Oncology Unit, EA 3181, University Hospital of Besançon, 2 place Saint-Jacques, 25000 Besançon, France. · Department of Medical Oncology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Department of Medical Oncology, ICO Centre René Gauducheau, boulevard Jacques Monod, 44805 Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, 114 rue Edouard-Vaillant, 94800 Villejuif, France. · Department of Medical Oncology, Institut Claudius Régaud, 20/24 Rue du Pont Saint Pierre, 31300 Toulouse, France. · R&D UNICANCER, 101 rue de Tolbiac, 75654 Paris, France. · Department of Pathology, Institut Claudius Régaud, 20/24 rue du Pont Saint Pierre, 31300 Toulouse, France. · Pubmed 26260807
  • CHU de Toulouse, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Réseau de cancérologie de Midi-Pyrénées ONCOMIP, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Laboratoire d'anatomie et de cytologie pathologiques des feuillants, 116, route d'Espagne, 31000 Toulouse, France. · Institut Claudius-Regaud, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Clinique Claude-Bernard, service d'anatomie et de cytologie pathologiques, 1, rue Père-Colombier, 81030 Albi cedex 09, France. · Laboratoire d'anatomie et de cytologie pathologiques, 13, rue Carnot, 65000 Tarbes, France. · Laboratoire d'anatomie et de cytologie pathologiques, 9, rue Viscose, 31100 Toulouse, France. · Laboratoire d'anatomie et de cytologie pathologiques de Montauban, 43, avenue Charles-de-Gaulle, 82000 Montauban, France. · Laboratoire d'anatomie et de cytologie pathologiques, 62, boulevard des récollets, 31400 Toulouse, France. · Centre de pathologie des coteaux, 5, rue Boyssonne, BP 14001, 31078 Toulouse cedex 4, France. · Université Paul-Sabatier, département TIC/TICE et multimédia (DTSI), 118, route de Narbonne, 31062 Toulouse cedex 9, France. · Institut Claudius-Regaud, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. Electronic address: · Pubmed 26384691
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Department of Pathology and CRB Ferdinand Cabanne, Centre Georges Francois Leclerc, 21000, Dijon, France. · Departments of Anatomic Pathology and Oncology, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil. · Departments of Anatomic Pathology and Oncology, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil. · Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, 31059, Toulouse, France. · Department of Pathology, Centre Jean Perrin, and University of Auvergne, 63000, Clermont Ferrand, France. · Department of Pathology, Centre Oscar Lambret, 59000, Lille, France. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Medical Oncology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Affiliate Member, Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Affiliate Member, Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Pubmed 25994018
2014
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Tumor Bank, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Pathology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · Département de Biologie et de Pathologie, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31052, France. · Département d'Oncologie Médicale, Institut de Cancérologie de l'Ouest-René Gauducheau, Boulevard Jacques Monod, Saint-Herblain, Nantes, 44805, France. · R&D UNICANCER, UNICANCER, Rue de Tolbiac 101, Paris, Cedex 13 75654, France. · Département d'Oncologie Médicale, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31300, France. · Department of Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, Brussels, 1200, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Pubmed 25416589
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
2012
  • Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. · Institut Claudius Regaud, 31052 Toulouse, France. · CRUK Clinical Trials Unit, The Institute of Cancer Research, Sutton SM2 5NG, UK. · Institut Curie, 75005 Paris, France. · Institut Bergonié, 33076 Bordeaux, France. · Centre Hospitalier Universitaire, 37044 Tours, France. · Centre Hospitalier Régional, 45100 Orléans, France. · Signal Transduction Laboratory, Cancer Research UK London Research Institute, London WC2A 3LY, UK. · Pubmed 22025283
2014
  • Pathology Department, Institut Claudius Regaud, Toulouse, France. · Pubmed 24117939
2011
  • Département de biologie et de pathologie, institut Claudius-Regaud, Toulouse cedex, France. · Pubmed 22172117
  • Institut Claudius-Regaud, Toulouse, France. · Pubmed 21183390
Probable:    INSERM France      
2017
  • Claudius Regaud Institute, Institut Universitaire du Cancer de Toulouse (UICT)-Oncopole, Department of Medical Oncology and Inserm UMR 1037, Team "Cholesterol Metabolism and Therapeutic Innovations", Cancer Research Center, Toulouse, France. · Department of Pathology, Jean Perrin Institute, Clermont Ferrand, France. · Department of Surgery, Private Institute, Aubagne, France. · Department of Surgery, Paoli-Calmettes Institute, Marseille, France. · Breast Institute of Orangerie, Strasbourg, France. · Department of Breast and Gynecologic Surgery, Union Clinic, Saint Jean, France. · Department of Radiotherapy, Roanne Hospital, Roanne, France. · Department of Radiotherapy, Marie Curie Institute, Valence, France. · Roche, France. · Department of Breast Surgery, Oscar Lambret Anti-Cancer Center-UNICANCER, Lille, France. · Assistance Publique Hôpitaux de Paris (AP-HP), Department of Medical Oncology, Tenon Hospital, and University of Pierre et Marie Curie (UPMC), Paris. · Assistance Publique Hôpitaux de Paris (AP-HP), Department of Radiation Oncology and Henri Mondor Breast Center, INSERM U955 E07, and University of Paris-Est Créteil (UPEC), France. Electronic address: · Pubmed 27856201
2016
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
2015
  • CNRS, LAAS, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Institut Claudius Regaud, Biology and Pathology Department; INSERM UMR1037, Toulouse, France. · CNRS, LAAS, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Institut Claudius Regaud, Biology and Pathology Department; INSERM UMR1037, Toulouse, France. · Institut Claudius Regaud, Biology and Pathology Department; INSERM UMR1037, Toulouse, France. · Dendris SAS, 8 Rue de Cugnaux, 31300, Toulouse, France. · Institut Claudius Regaud, Oncology Department, Toulouse, France. · Institut Claudius Regaud, Biology and Pathology Department; INSERM UMR1037, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Dendris SAS, 8 Rue de Cugnaux, 31300, Toulouse, France. · CNRS, LAAS, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Pubmed 25888889
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2013
  • Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm, Institut Paoli-Calmettes IPC, 13273 Marseille, France. · Pubmed 23117074
2011
  • INSERM U563, Université Paul Sabatier, Toulouse, France. · Pubmed 21498638
2010
  • INSERM U563, Centre de Physiopathologie de Toulouse-Purpan, Toulouse F-31300, France. · Pubmed 21042713
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 38 total) written by Magali Lacroix Triki about Breast Neoplasms:

  • Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner. 2019
  • Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis. 2019
  • UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer. 2018
  • Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases. 2018
  • The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial). 2018
  • Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. 2018
  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research. 2017
  • Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor. 2017
  • [Evaluation of tumor-infiltrating lymphocytes in breast cancer: How to use the 2014 international guidelines?] 2017
  • Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study. 2017
Show List of Full Article Records
Google Searches

Learn more about Magali Lacroix Triki using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Gustave Roussy
Miscellaneous institutions in Toulouse
INSERM France
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Gustave Roussy
2019
  • Institut de Génétique Humaine, CNRS, Université de Montpellier, Equipe Labellisée Ligue Contre le Cancer, 34396, Montpellier, France. · Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany. · Cancer Research Center of Toulouse, INSERM U1037, CNRS ERL5294, University of Toulouse 3, 31037, Toulouse, France. · Clinical trials Office - Biostatistics Unit, Institute Claudius Regaud, Institute Universitaire du Cancer Toulouse-Oncopole (IUCT-O), 31100, Toulouse, France. · Thoracic Oncology Department, Toulouse University Hospital, University Paul Sabatier, 31062, Toulouse, France. · Gustave Roussy Cancer Campus, 94805, Villejuif, France. · The Institute of Cancer Research, London, SW3 6JB, UK. · Institut de Génétique Humaine, CNRS, Université de Montpellier, Equipe Labellisée Ligue Contre le Cancer, 34396, Montpellier, France. · Institut de Génétique Humaine, CNRS, Université de Montpellier, Equipe Labellisée Ligue Contre le Cancer, 34396, Montpellier, France. · Pubmed 30796221
  • Department of Molecular Medicine, INSERM U981, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94800, Villejuif, France. · LabEx LERMIT, University Paris Saclay, 5 Rue J-B Clément, 92296, Châtenay-Malabry, France. · University Paris Sud, 63 rue Gabriel Peri, 94270, Le Kremlin-Bicetre, France. · Inovarion, 75013, Paris, France. · Department of Medical Oncology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94800, Villejuif, France. · Pathology Department, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France. · Department of Medical Biology and Pathology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Translational Research Department, Breast Cancer Biology Group, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005 Paris, France. · Department of Molecular Medicine, INSERM U981, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94800, Villejuif, France. · LabEx LERMIT, University Paris Saclay, 5 Rue J-B Clément, 92296, Châtenay-Malabry, France. · University Paris Sud, 63 rue Gabriel Peri, 94270, Le Kremlin-Bicetre, France. · Pubmed 30368744
2018
  • ICO René Gauducheau, Saint-Herblain, France. Electronic address: · Gustave Roussy, Villejuif, France. · Centre Val D'Aurelle, Montpellier, France. · University Hospitals Leuven and KULeuven, Leuven, Belgium. · Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Centre François Baclesse, Caen, France. · Centre Georges-François Leclerc, Dijon, France. · Centre Léon Bérard, Lyon, France. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jean Godinot, Reims, France. · Centre Alexis Vautrin, Nancy, France. · Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · University of AntwerpAZ, Belgium. · Clinique Tivoli, Bordeaux, France. · Polyclinique de Courlancy, Reims, France. · CH de Fleyriat, Bourg en Bresse, France. · Grand Hopital de Charleroi, Charleroi, Belgium. · R&D UNICANCER, UCBG, Paris, France. · Institut Claudius Regaud, IUCT Oncopole, Toulouse, France. · Pubmed 30267987
  • Département de Biologie et Pathologie des Tumeurs, Centre Georges-François Leclerc - Unicancer, 1 rue Professeur Marion, 21000, Dijon, France. · Département de Biopathologie, Institut Bergonié, 229 cours de l'Argonne, 33076, Bordeaux, France. · Département de Biologie et Pathologie des Tumeurs, Centre Georges-François Leclerc - Unicancer, 1 rue Professeur Marion, 21000, Dijon, France. · Département de Pathologie, Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Service d'Anatomie et Cytologie Pathologiques, Centre Hospitalier Universitaire de Besançon, 25030, Besançon Cedex, France. · Cypath Lyon, 201 route de Genas, 69100, Villeurbanne, France. · Département de Pathologie, Institut Curie, Saint Cloud, 35 rue Dailly, 92210, Saint Cloud, France. · Medipath Cannes-Antibes-Grasse, 80 allée des ormes, 06250, Mougins, France. · Pathologie Nord Unilabs, 60 boulevard Jean Baptiste Lebas, 59000, Lille, France. · Centre de Pathologie, 13 rue Carnot, 65000, Tarbes, France. · Atalante Pathologie, 10 rue J-Louis Bertrand -BP11633, 35016, Rennes cedex, France. · Pubmed 29785016
  • Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Biostatistics, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005 Paris & Saint-Cloud, France. · Department of Medical Oncology, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Bergonié, 229 Cours de L'Argonne, 33000 Bordeaux, France. · Department of Medical Oncology, Institut Du Cancer de Montpellier, 208 Rue des Apothicaires, 34298 Montpellier, France. · Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011 Clermont Ferrand, France. · Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059 Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes & Angers, 15 rue André Boquel, 49055 Angers, France. · Department of Medical Oncology, Centre Antoine Lacassagne, 33 Avenue de Valambrose, 06189 Nice, France. · Department of Medical Oncology, Centre François Baclesse, 3 Avenue du Général Harris, 14000 Caen, France. · Department of Medical Oncology, Centre Georges François Leclerc, 1 rue Professeur Marion, 21079 Dijon, France. · Medical Oncology Department, Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000 Lille, France. · Medical Oncology Department, Centre Eugéne Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000 Rennes, France. · INSERM CIC1401, Institut Bergonie, Comprehensive Cancer Center, F-33000 Bordeaux, France. · Department of Medical Oncology, Centre Paul Strauss, 3 Rue de la Porte de l'Hôpital, 67000 Strasbourg, France. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, 1 Rue du Général Koenig, 51100 Reims, France. · Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, 6 Avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France. · Department of Medical Oncology, Centre Henri Becquerel, Rue d'Amiens, 76000 Rouen, France. · Department of BioPathology, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654 Paris, France. · Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Pubmed 29660596
2017
  • Département de biologie et pathologie médicales, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Service de pathologie, centre François-Baclesse, avenue du Général-Harris, 14076 Caen cedex 5, France. · Département de biologie et pathologie médicales, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Pubmed 28159402
2016
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Miscellaneous institutions in Toulouse
2018
  • Department of Biopathology, Centre Jean Perrin and EA 4677 ERTICa, Université d'Auvergne, 58 rue Montalembert, 63000, Clermont-Ferrand, France. · Department of Biostatistics, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Institut Curie, Paris, France. · Genomic Health Inc, Redwood City, CA, USA. · University of California, San Francisco, CA, USA. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France. · Department of Pathology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Centre Val d'Aurelle, Montpellier, France. · Department of Pathology, Institut de Cancérologie de l'Ouest (site René Gauducheau), Nantes, Saint-Herblain, France. · Unicancer, Paris, France. · Department of Medical Oncology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Pubmed 29728098
2017
  • Team "Cholesterol Metabolism and Therapeutic Innovations," Cancer Research Center of Toulouse (CRCT), UMR 1037, Université de Toulouse, CNRS, Inserm, UPS, 31037 Toulouse, France. · Université Paul Sabatier, 31062 Toulouse, France. · Affichem, 31400 Toulouse, France. · Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, 31059 Toulouse, France. · Vascular Biology, Atherothrombosis & Mass Spectrometry Laboratory, Sapienza University of Rome, 04100 Latina, Italy. · l'Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, University of Montpellier, F-34298 Montpellier, France. · INSERM/UPS-US006/Centre Régional d'Exploration Fonctionnelle et Ressources Expérimentales, Service d'Histopathologie, Centre Hospitalier Universitaire Purpan, 31024 Toulouse, France. · Pôle Technologique, Cancer Research Center of Toulouse (CRCT), Plateau Interactions Moléculaires, INSERM-UMR1037, 31037 Toulouse, France. · Team "Cholesterol Metabolism and Therapeutic Innovations," Cancer Research Center of Toulouse (CRCT), UMR 1037, Université de Toulouse, CNRS, Inserm, UPS, 31037 Toulouse, France; · Pubmed 29078321
2016
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
2015
  • Département de pathologie, IUCT-Oncopole 1, avenue Irène Joliot-Curie, 31059 Toulouse cedex 9, France. · Département de pathologie, IUCT-Oncopole 1, avenue Irène Joliot-Curie, 31059 Toulouse cedex 9, France. Electronic address: · Pubmed 26118875
  • Department of Medical Oncology, Institut du Cancer de Montpellier, 208 avenue des Apothicaires, 34298 Montpellier Cedex 5, France. · Department of Pathology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Methodological and Quality of Life in Oncology Unit, EA 3181, University Hospital of Besançon, 2 place Saint-Jacques, 25000 Besançon, France. · Department of Medical Oncology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Department of Medical Oncology, ICO Centre René Gauducheau, boulevard Jacques Monod, 44805 Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, 114 rue Edouard-Vaillant, 94800 Villejuif, France. · Department of Medical Oncology, Institut Claudius Régaud, 20/24 Rue du Pont Saint Pierre, 31300 Toulouse, France. · R&D UNICANCER, 101 rue de Tolbiac, 75654 Paris, France. · Department of Pathology, Institut Claudius Régaud, 20/24 rue du Pont Saint Pierre, 31300 Toulouse, France. · Pubmed 26260807
  • CHU de Toulouse, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Réseau de cancérologie de Midi-Pyrénées ONCOMIP, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Laboratoire d'anatomie et de cytologie pathologiques des feuillants, 116, route d'Espagne, 31000 Toulouse, France. · Institut Claudius-Regaud, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Clinique Claude-Bernard, service d'anatomie et de cytologie pathologiques, 1, rue Père-Colombier, 81030 Albi cedex 09, France. · Laboratoire d'anatomie et de cytologie pathologiques, 13, rue Carnot, 65000 Tarbes, France. · Laboratoire d'anatomie et de cytologie pathologiques, 9, rue Viscose, 31100 Toulouse, France. · Laboratoire d'anatomie et de cytologie pathologiques de Montauban, 43, avenue Charles-de-Gaulle, 82000 Montauban, France. · Laboratoire d'anatomie et de cytologie pathologiques, 62, boulevard des récollets, 31400 Toulouse, France. · Centre de pathologie des coteaux, 5, rue Boyssonne, BP 14001, 31078 Toulouse cedex 4, France. · Université Paul-Sabatier, département TIC/TICE et multimédia (DTSI), 118, route de Narbonne, 31062 Toulouse cedex 9, France. · Institut Claudius-Regaud, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. Electronic address: · Pubmed 26384691
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Department of Pathology and CRB Ferdinand Cabanne, Centre Georges Francois Leclerc, 21000, Dijon, France. · Departments of Anatomic Pathology and Oncology, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil. · Departments of Anatomic Pathology and Oncology, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil. · Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, 31059, Toulouse, France. · Department of Pathology, Centre Jean Perrin, and University of Auvergne, 63000, Clermont Ferrand, France. · Department of Pathology, Centre Oscar Lambret, 59000, Lille, France. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Medical Oncology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Affiliate Member, Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Affiliate Member, Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Pubmed 25994018
2014
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Tumor Bank, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Pathology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · Département de Biologie et de Pathologie, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31052, France. · Département d'Oncologie Médicale, Institut de Cancérologie de l'Ouest-René Gauducheau, Boulevard Jacques Monod, Saint-Herblain, Nantes, 44805, France. · R&D UNICANCER, UNICANCER, Rue de Tolbiac 101, Paris, Cedex 13 75654, France. · Département d'Oncologie Médicale, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31300, France. · Department of Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, Brussels, 1200, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Pubmed 25416589
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
2012
  • Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. · Institut Claudius Regaud, 31052 Toulouse, France. · CRUK Clinical Trials Unit, The Institute of Cancer Research, Sutton SM2 5NG, UK. · Institut Curie, 75005 Paris, France. · Institut Bergonié, 33076 Bordeaux, France. · Centre Hospitalier Universitaire, 37044 Tours, France. · Centre Hospitalier Régional, 45100 Orléans, France. · Signal Transduction Laboratory, Cancer Research UK London Research Institute, London WC2A 3LY, UK. · Pubmed 22025283
2014
  • Pathology Department, Institut Claudius Regaud, Toulouse, France. · Pubmed 24117939
2011
  • Département de biologie et de pathologie, institut Claudius-Regaud, Toulouse cedex, France. · Pubmed 22172117
  • Institut Claudius-Regaud, Toulouse, France. · Pubmed 21183390
INSERM France
2017
  • Claudius Regaud Institute, Institut Universitaire du Cancer de Toulouse (UICT)-Oncopole, Department of Medical Oncology and Inserm UMR 1037, Team "Cholesterol Metabolism and Therapeutic Innovations", Cancer Research Center, Toulouse, France. · Department of Pathology, Jean Perrin Institute, Clermont Ferrand, France. · Department of Surgery, Private Institute, Aubagne, France. · Department of Surgery, Paoli-Calmettes Institute, Marseille, France. · Breast Institute of Orangerie, Strasbourg, France. · Department of Breast and Gynecologic Surgery, Union Clinic, Saint Jean, France. · Department of Radiotherapy, Roanne Hospital, Roanne, France. · Department of Radiotherapy, Marie Curie Institute, Valence, France. · Roche, France. · Department of Breast Surgery, Oscar Lambret Anti-Cancer Center-UNICANCER, Lille, France. · Assistance Publique Hôpitaux de Paris (AP-HP), Department of Medical Oncology, Tenon Hospital, and University of Pierre et Marie Curie (UPMC), Paris. · Assistance Publique Hôpitaux de Paris (AP-HP), Department of Radiation Oncology and Henri Mondor Breast Center, INSERM U955 E07, and University of Paris-Est Créteil (UPEC), France. Electronic address: · Pubmed 27856201
2016
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
2015
  • CNRS, LAAS, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Institut Claudius Regaud, Biology and Pathology Department; INSERM UMR1037, Toulouse, France. · CNRS, LAAS, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Institut Claudius Regaud, Biology and Pathology Department; INSERM UMR1037, Toulouse, France. · Institut Claudius Regaud, Biology and Pathology Department; INSERM UMR1037, Toulouse, France. · Dendris SAS, 8 Rue de Cugnaux, 31300, Toulouse, France. · Institut Claudius Regaud, Oncology Department, Toulouse, France. · Institut Claudius Regaud, Biology and Pathology Department; INSERM UMR1037, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Dendris SAS, 8 Rue de Cugnaux, 31300, Toulouse, France. · CNRS, LAAS, F-31400, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · Université de Toulouse; INSA, UPS, INP; LISBP, F-31077, Toulouse, France. · INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés, F-31400, Toulouse, France. · CNRS, UMR5504, F-31400, Toulouse, France. · Pubmed 25888889
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2013
  • Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm, Institut Paoli-Calmettes IPC, 13273 Marseille, France. · Pubmed 23117074
2011
  • INSERM U563, Université Paul Sabatier, Toulouse, France. · Pubmed 21498638
2010
  • INSERM U563, Centre de Physiopathologie de Toulouse-Purpan, Toulouse F-31300, France. · Pubmed 21042713
Institut Universitaire de France
2017
  • Claudius Regaud Institute, Institut Universitaire du Cancer de Toulouse (UICT)-Oncopole, Department of Medical Oncology and Inserm UMR 1037, Team "Cholesterol Metabolism and Therapeutic Innovations", Cancer Research Center, Toulouse, France. · Department of Pathology, Jean Perrin Institute, Clermont Ferrand, France. · Department of Surgery, Private Institute, Aubagne, France. · Department of Surgery, Paoli-Calmettes Institute, Marseille, France. · Breast Institute of Orangerie, Strasbourg, France. · Department of Breast and Gynecologic Surgery, Union Clinic, Saint Jean, France. · Department of Radiotherapy, Roanne Hospital, Roanne, France. · Department of Radiotherapy, Marie Curie Institute, Valence, France. · Roche, France. · Department of Breast Surgery, Oscar Lambret Anti-Cancer Center-UNICANCER, Lille, France. · Assistance Publique Hôpitaux de Paris (AP-HP), Department of Medical Oncology, Tenon Hospital, and University of Pierre et Marie Curie (UPMC), Paris. · Assistance Publique Hôpitaux de Paris (AP-HP), Department of Radiation Oncology and Henri Mondor Breast Center, INSERM U955 E07, and University of Paris-Est Créteil (UPEC), France. Electronic address: · Pubmed 27856201
2016
  • Department of Radiation Oncology, Institut Claudius Regaud / Institut Universitaire du Cancer de Toulouse - Oncopôle, Toulouse, Cedex, France. · Department of Pathology, Institut Claudius Regaud / Institut Universitaire du Cancer de Toulouse - Oncopôle, Toulouse, Cedex, France. · Department of Biostatistics, Institut Claudius Regaud / Institut Universitaire du Cancer de Toulouse - Oncopôle, Toulouse, Cedex, France. · Department of Surgical Oncology, Institut Claudius Regaud / Institut Universitaire du Cancer de Toulouse - Oncopôle, Toulouse, Cedex, France. · Département of Medical Oncology, Institut Claudius Regaud / Institut Universitaire du Cancer de Toulouse - Oncopôle, Toulouse, Cedex, France. · Pubmed 27261365
Universite de Toulouse
2016
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
2011
  • INSERM U563, Université Paul Sabatier, Toulouse, France. · Pubmed 21498638
Miscellaneous institutions in Paris
2014
  • Groupe d'étude des facteurs pronostiques immunohistochimiques dans le cancer du sein, Unicancer, 101, rue de Tolbiac, 75654 Paris cedex 13, France. · Groupe d'étude des facteurs pronostiques immunohistochimiques dans le cancer du sein, Unicancer, 101, rue de Tolbiac, 75654 Paris cedex 13, France. Electronic address: · Pubmed 25439989
  • Groupe d'étude des facteurs pronostiques immunohistochimiques dans le cancer du sein, Unicancer, 101, rue de Tolbiac, 75654 Paris cedex 13, France. · Groupe d'étude des facteurs pronostiques immunohistochimiques dans le cancer du sein, Unicancer, 101, rue de Tolbiac, 75654 Paris cedex 13, France. Electronic address: · Pubmed 25439988
University of London
2012
  • Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. · Institut Claudius Regaud, 31052 Toulouse, France. · CRUK Clinical Trials Unit, The Institute of Cancer Research, Sutton SM2 5NG, UK. · Institut Curie, 75005 Paris, France. · Institut Bergonié, 33076 Bordeaux, France. · Centre Hospitalier Universitaire, 37044 Tours, France. · Centre Hospitalier Régional, 45100 Orléans, France. · Signal Transduction Laboratory, Cancer Research UK London Research Institute, London WC2A 3LY, UK. · Pubmed 22025283
2010
  • Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Pubmed 21228925
  • The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. · Pubmed 20815046
  • The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. · Pubmed 20693983
2012
  • Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Pubmed 22486256
2011
  • Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. · Pubmed 21076461
77 Other Locations Show
Yearly article counts 24436622450